ELVN

Enliven Therapeutics, Inc. Common Stock

25.35

USD

ELVN Earnings Reports

Positive Surprise Ratio

ELVN beat 16 of 22 last estimates.

73%

Next Report

Date of Next Report

Mar 11, 2026

Estimate for Q4 25 (Revenue/ EPS)

$8.50K

-$0.38

Implied change from Q3 25 (Revenue/ EPS)

+18.75%

Implied change from Q4 24 (Revenue/ EPS)

-17.39%

Enliven Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, ELVN reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.44 USD, resulting in a 27.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.15% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 8.50 thousand USD, implying an increase of 18.75% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Enliven Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Enliven Therapeutics, Inc. Common Stock reported EPS of -$0.32, beating estimates by 27.67%, and revenue of $0.00, 0% as expectations.

How did the market react to Enliven Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -0.15%, changed from $20.30 before the earnings release to $20.27 the day after.

When is Enliven Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 11, 2026.

What are the forecasts for Enliven Therapeutics, Inc. Common Stock's next earnings report?

Based on 12 analysts, Enliven Therapeutics, Inc. Common Stock is expected to report EPS of -$0.38 and revenue of $8.50K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.